2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver

C102H70Ag3N13O2-9 — CID 157255988

IUPAC2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver
SMILESCN1c2ccc(-c3cccc4c3[c-]cn4C)[c-]c2N(c2nc3c(-c4[c-]cccc4)cccc3n2C)c2ccccc21.Cn1cc[c-]c1-n1ccc2ccc(-n3c4ccccc4c4ccc(-n5c6[c-]cccc6c6ccccc65)nc43)[c-]c21.[Ag].[Ag].[Ag].[c-]1ccccc1C[C-](CN(c1ccccc1)c1nc2c(-n3[c-]ccc3)coc2o1)c1ccccc1
InChIInChI=1S/C36H22N5.C36H26N5.C30H22N3O2.3Ag/c1-38-21-8-15-35(38)39-22-20-24-16-17-25(23-33(24)39)40-30-12-5-4-11-28(30)29-18-19-34(37-36(29)40)41-31-13-6-2-9-26(31)27-10-3-7-14-32(27)41;1-38-22-21-28-26(13-9-17-29(28)38)25-19-20-31-34(23-25)41(32-16-8-7-15-30(32)39(31)2)36-37-35-27(24-11-5-4-6-12-24)14-10-18-33(35)40(36)3;1-4-12-23(13-5-1)20-25(24-14-6-2-7-15-24)21-33(26-16-8-3-9-17-26)30-31-28-27(22-34-29(28)35-30)32-18-10-11-19-32;;;/h2-13,16-22H,1H3;4-11,13-20,22H,1-3H3;1-12,14-18,22H,20-21H2;;;/q3*-3;;;
InChIKeyLTWUYVVOWWMLSV-UHFFFAOYSA-N
MW1833.37 g/mol
LogP23.12
Rot. Bonds14

About 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver

2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver (PubChem CID 157255988) has the molecular formula C102H70Ag3N13O2-9 and a molecular weight of 1833.37 g/mol. Its IUPAC name is 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver.

Molecular Properties

Compound Name2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver
PubChem CID157255988
Molecular FormulaC102H70Ag3N13O2-9
Molecular Weight1833.37 g/mol
Exact Mass1829.30
IUPAC Name2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver
SMILESCN1c2ccc(-c3cccc4c3[c-]cn4C)[c-]c2N(c2nc3c(-c4[c-]cccc4)cccc3n2C)c2ccccc21.Cn1cc[c-]c1-n1ccc2ccc(-n3c4ccccc4c4ccc(-n5c6[c-]cccc6c6ccccc65)nc43)[c-]c21.[Ag].[Ag].[Ag].[c-]1ccccc1C[C-](CN(c1ccccc1)c1nc2c(-n3[c-]ccc3)coc2o1)c1ccccc1
InChIInChI=1S/C36H22N5.C36H26N5.C30H22N3O2.3Ag/c1-38-21-8-15-35(38)39-22-20-24-16-17-25(23-33(24)39)40-30-12-5-4-11-28(30)29-18-19-34(37-36(29)40)41-31-13-6-2-9-26(31)27-10-3-7-14-32(27)41;1-38-22-21-28-26(13-9-17-29(28)38)25-19-20-31-34(23-25)41(32-16-8-7-15-30(32)39(31)2)36-37-35-27(24-11-5-4-6-12-24)14-10-18-33(35)40(36)3;1-4-12-23(13-5-1)20-25(24-14-6-2-7-15-24)21-33(26-16-8-3-9-17-26)30-31-28-27(22-34-29(28)35-30)32-18-10-11-19-32;;;/h2-13,16-22H,1H3;4-11,13-20,22H,1-3H3;1-12,14-18,22H,20-21H2;;;/q3*-3;;;
InChIKeyLTWUYVVOWWMLSV-UHFFFAOYSA-N
XLogP23.12
TPSA109.18 Ų
H-Bond Donors
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms120
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001833.37
LogP ≤ 523.12
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 140690382
CID 140690382
CID 140690412
CID 140690412
6-(1,6-dimethyl-3H-pyrrolo[2,3-b]pyrrol-1-ium-3-id-4-yl)-N-[[(E)-furo[3,2-d][1,3]oxazol-6-ylmethylideneamino]methyl]-N-phenylpyridin-2-amine;palladium
CID 140690606
CID 140690754
CID 140690754
CID 140690774
CID 140690774
CID 157126532
CID 157126532
10,23-Dioxa-12,14,17,34-tetraza-6,41-diazoniatridecacyclo[22.19.0.02,6.02,41.03,22.04,19.05,12.07,11.013,18.027,43.028,33.034,42.035,40]tritetraconta-1(24),3(22),4(19),5,7(11),8,13,15,17,20,25,27(43),28,30,32,35,37,39,41-nonadecaene;10,23-dioxa-12,14,34-triaza-6,41-diazoniatridecacyclo[22.19.0.02,6.02,41.03,22.04,19.05,12.07,11.013,18.027,43.028,33.034,42.035,40]tritetraconta-1(24),3(22),4(19),5,7(11),8,13(18),14,16,20,25,27(43),28,30,32,35,37,39,41-nonadecaene;10,23-dioxa-12,17,34-triaza-6,41-diazoniatridecacyclo[22.19.0.02,6.02,41.03,22.04,19.05,12.07,11.013,18.027,43.028,33.034,42.035,40]tritetraconta-1(24),3(22),4(19),5,7(11),8,13(18),14,16,20,25,27(43),28,30,32,35,37,39,41-nonadecaene
CID 157127093
tetrakis(chloropalladium(1+));9-(1-methylbenzimidazol-2-yl)-2-[4-(4-phenylphenyl)-2-pyridinyl]-1H-carbazol-1-ide;4-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]-[1,3]oxazolo[4,5-b]indole;2-[3-[4-(4-phenylphenyl)-2-pyridinyl]benzene-2-id-1-yl]oxy-1,3-benzoxazole;4-(4-phenylphenyl)-2-(3-pyridin-2-yloxy-2H-pyrrol-2-id-1-yl)pyridine
CID 157183099
CID 157192645
CID 157192645
6-(3H-1-benzofuran-3-id-4-yl)-N-[6-(7H-indol-7-id-1-yl)-2-pyridinyl]-N-phenylpyridin-2-amine;6-(3,4-dimethylpyrrolo[2,3-d]imidazol-3-ium-1-id-6-yl)-N-[(3H-furo[2,3-b]furan-3-id-4-ylmethylideneamino)methyl]-N-phenylpyridin-2-amine;2-(1-methyl-2H-indol-2-id-3-yl)-4-(6-pyrazol-1-yl-2-pyridinyl)pyrrolo[2,3-d][1,3]oxazole;9-(6-phenyl-2-pyridinyl)-2-pyridin-2-ylpyrido[2,3-b]indole;bis(rhodium);bis(rhodium(2+))
CID 157224593
6-(3H-1-benzofuran-3-id-4-yl)-N-[6-(7H-indol-7-id-1-yl)-2-pyridinyl]-N-phenylpyridin-2-amine;6-(3,4-dimethyl-6H-pyrrolo[2,3-d]imidazole-3,4-diium-6-id-1-yl)-N-[(furo[3,2-d][1,3]oxazol-6-ylmethylideneamino)methyl]-N-phenylpyridin-2-amine;manganese;tris(manganese(2+));2-(1-methyl-2H-indol-2-id-3-yl)-4-[6-(2H-pyrrol-2-id-1-yl)-2-pyridinyl]pyrrolo[2,3-d][1,3]oxazole;2-phenyl-9-(6-phenyl-2-pyridinyl)pyrido[2,3-b]indole
CID 157290463
2-(4b,8a-dihydro-1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)pyrrolo[2,3-b]pyridin-6-yl]pyrido[2,3-b]indole;benzyl-phenyl-[(N-(6-pyrazol-1-ylfuro[3,2-d][1,3]oxazol-2-yl)anilino)methyl]phosphanium;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)pyrido[3,2-b]quinoxaline;2-phenyl-11-(8-phenylquinolin-2-yl)-5,6-dihydropyrido[2,3-b][1]benzazepine;platinum;tris(platinum(2+))
CID 157302716

Frequently Asked Questions

What is the IUPAC name of 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver?
The IUPAC name of 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver (CID 157255988) is 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver.
What is the SMILES notation for 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver?
The canonical SMILES for 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver is CN1c2ccc(-c3cccc4c3[c-]cn4C)[c-]c2N(c2nc3c(-c4[c-]cccc4)cccc3n2C)c2ccccc21.Cn1cc[c-]c1-n1ccc2ccc(-n3c4ccccc4c4ccc(-n5c6[c-]cccc6c6ccccc65)nc43)[c-]c21.[Ag].[Ag].[Ag].[c-]1ccccc1C[C-](CN(c1ccccc1)c1nc2c(-n3[c-]ccc3)coc2o1)c1ccccc1.
What is the InChIKey of 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver?
The InChIKey is LTWUYVVOWWMLSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H22N5.C36H26N5.C30H22N3O2.3Ag/c1-38-21-8-15-35(38)39-22-20-24-16-17-25(23-33(24)39)40-30-12-5-4-11-28(30)29-18-19-34(37-36(29)40)41-31-13-6-2-9-26(31)27-10-3-7-14-32(27)41;1-38-22-21-28-26(13-9-17-29(28)38)25-19-20-31-34(23-25)41(32-16-8-7-15-30(32)39(31)2)36-37-35-27(24-11-5-4-6-12-24)14-10-18-33(35)40(36)3;1-4-12-23(13-5-1)20-25(24-14-6-2-7-15-24)21-33(26-16-8-3-9-17-26)30-31-28-27(22-34-29(28)35-30)32-18-10-11-19-32;;;/h2-13,16-22H,1H3;4-11,13-20,22H,1-3H3;1-12,14-18,22H,20-21H2;;;/q3*-3;;;.
What are the key properties of 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver?
2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver has a molecular weight of 1833.37 g/mol, XLogP of 23.12, 14 rotatable bonds, 0 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1H-carbazol-1-id-9-yl)-9-[1-(1-methyl-3H-pyrrol-3-id-2-yl)-7H-indol-7-id-6-yl]pyrido[2,3-b]indole;5-methyl-2-(1-methyl-3H-indol-3-id-4-yl)-10-(1-methyl-4-phenylbenzimidazol-2-yl)-1H-phenazin-1-ide;N-phenyl-N-(2-phenyl-3-phenylpropyl)-6-(2H-pyrrol-2-id-1-yl)furo[3,2-d][1,3]oxazol-2-amine;silver is sourced from PubChem (CID 157255988), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).